Download App
PAPER TRADE
Download App
Login
Feedback
AUROPHARMA
newsbot
Reputation: 200,298 •
Aug 14, 2020 7:06 PM
COVID-19 vaccine: Aurobindo Pharma expects phase-I, II trials by end of 2020
He said the vaccine for COVID-19 is being developed by Profectus BioSciences Inc in US, which was acquired by AurobindoPharmas subsidiary Auro Vaccines LLC.
The Economic Times
https://economictimes.indiatimes.com/industry/healthcare/...
#AUROPHARMA
Vote
Comment
Share
NSE:AUROPHARMA price when posted: 891.15